Treatment demonstrated a good safety profile in the overall patient population during the 12-week induction phase
News
Waiting times for cancer referrals highest on record
93% of people suspected by GPs to have cancer should be seen by a specialist within two weeks but this has fallen to just 75%
The NHS: Prevention, Personalisation and Performance
The government’s planned ‘Road to Recovery’ will have a new focus on prevention
UK COVID-19 cases rising among those aged 55 and older
Certain areas in the UK have been experiencing a significant increase in COVID-19 cases in recent days
Study into prophylaxis treatment meets key endpoints
Results showed a clinically meaningful prevention of bleeds in people with severe haemophilia A
SMC approval welcome news for breast cancer patients
Trodelvy is accepted for use in mTNBC patients who have already received two or more systemic therapies
Gene team supports therapies for previously untreatable brain regions
Novartis and Voyager Therapeutics announce partnership to develop gene therapies for neurological disorders
Cell door: EMA grants ATMP classification to CELTIC-19
Advanced Therapy Medicinal Product classification for Ixaka Ltd’s chemically encapsulated lentiviral vector
Roche launches molecular system to increase diagnostic testing access
Fully-automated molecular system with small footprint provides greater flexibility for laboratories without much space
First treatment for adults across full spectrum of chronic heart failure
Largest unmet need in cardiovascular medicine finally receives approved therapy
Outbreaks of norovirus increasing in England
UKHSA reports an increase in norovirus cases throughout educational settings – particularly in nursery and childcare facilities
Annual obesity costs may soar to £58bn
New detailed datasets will more accurately map out the impact of obesity throughout UK
First RSV vaccine trial for infants offers significant results
The phase 3 MELODY study reveals that nirsevimab vaccine reduces lower respiratory tract infections
Previously untreatable lung cancer patients offered new therapy
NICE document recommends Amgen’s Lumykras (sotorasib) to treat non-small-cell lung cancer
Clinical jobs increase as R&D and lab roles experience record growth
The post-Brexit landscape has witnessed an exponential boom in life science careers
